Testing a non-invasive device to estimate central venous pressure in children
Tests a non-invasive ultrasound device, CPMX2, in children who already have a catheter.
Key facts
- Who runs it
- Compremium AG
- Where
- Washington D.C., United StatesSee the site
- Trial code
- Registry title
- Non-invasive Central Venous Pressure Estimation in Pediatric Patients
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 10 Mar 2025
- Planned end
- 31 Mar 2026
- Type of study
- Interventional
- Treatments tested
- CPMX2
- Record updated
- 18 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young people who already have a central venous catheter to measure central venous pressure, or who are having a cardiac catheterization. It tests a new device that measures this pressure without a catheter, using ultrasound.
- Age
- From birth to 21 years
- Sex
- Males and females can join
- Earlier treatment
- Must have a central venous catheter for central venous pressure monitoring as part of standard care, or be having a cardiac catheterization.
Main reasons for not taking part
- Weight under 2.5kg (6 lb (3 kg)) at enrollment
- Neck veins (both external jugular veins) not accessible because of vascular access or dressing
- Skin lesions on both sides of the neck that rule out a neck ultrasound
- Active bleeding
- Clinically unstable, as judged by the attending physician and/or surgeon
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Provision of signed and dated informed consent form
- Male or female
- Age: birth to 21 years of age
- Equipped with a central venous catheter (CVC) for central venous pressure (CVP) monitoring indication as part of standard of care, or undergoing cardiac catheterization
Who cannot take part
- Active bleeding
- Weight less than 2.5kg at the time of enrollment
- Bilateral external jugular veins not accessible due to vascular access or dressing
- Bilateral skin lesion contraindicating neck Ultrasound
- Clinically unstable, per clinical assessment by attending physician and/or surgeon
Where in United States
- Children's National HospitalWashington D.C., United StatesContact: Damon JudgesTaking people
About the trial
What the trial wants to find out
Central Venous Pressure (CVP) is a standard parameter for hemodynamic monitoring and is currently measured through the insertion of a catheter. The pediatric population is especially vulnerable to risks associated to this invasive procedure, including infection, thrombosis, and pneumothorax. The proposed pilot study will evaluate safety and preliminary efficacy of a new non-invasive ultrasound-based venous occlusion pressure (VOP) monitoring device (CPMX2) in children equipped with an invasive catheter for CVP monitoring as part of standard of care.
The group in the trial
- CPMX2 measurement armTreatment being tested
CPMX2 measurements will be compared against invasive CVP measurements
Treatment: CPMX2
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Non-invasive Central Venous Pressure Estimation in Pediatric Patients
- Plain-language title
- Testing a non-invasive device to estimate central venous pressure in childrenGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 18 September 2025